Sickle Cell Test Gets NCAA OK Despite Docs
By Cole Petrochko,
MedPage Today
| 01. 21. 2013
The National Collegiate Athletic Association (NCAA) has approved mandatory confirmation of sickle cell trait status in Division III student athletes, despite the objections of the American Society of Hematology (ASH).
NCAA delegates voted 254 to 200 in favor of the measure at the 2013 NCAA convention over the weekend.
Confirmation of sickle cell status will be required of all incoming student athletes in the 2013-2014 school year and for all athletes by 2014-2015. Mandatory sickle cell screening is already required by the NCAA in Division I and Division II athletes.
Last year, ASH
challenged the NCAA, declaring that athletes need not be tested for or disclose sickle cell trait status before participating in sporting events. In a statement released over the weekend, ASH said the "NCAA policy is medically groundless – perhaps even dangerous – and is focused more on protecting the NCAA from legal liability than protecting the health of student athletes."
Starting Aug. 1, the newly approved guidelines require schools to confirm the sickle cell trait status of incoming student athletes before participation in sports events in...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...